title: Redistribution of cyclic GMP in response to sodium butyrate in colon cells.
abstract: The effect of butyrate on the response to guanylin and Escherichia coli heat-stable enterotoxin, STa, was assessed in T84 cells and Caco-2 cells, cultured colon cell lines possessing the guanylyl cyclase C which is the receptor for these peptides. Butyrate treatment of these cells resulted in an apparent increase in cyclic GMP (cGMP) accumulation when the cGMP content of cells and the supernatant medium was measured. Butyrate treatment did not change the guanylyl cyclase activity or (125)I-STa binding parameters in T84 cells, but the butyrate effect was completely blocked by cycloheximide. Butyrate did not have any effect on STa-stimulated cGMP accumulation in COS cells transfected with the human or porcine GC-C. Further experiments showed that butyrate treatment caused a large increase in the cGMP released into the culture medium, and in cells grown in polarized fashion in Transwell inserts, cGMP efflux was predominantly from the basolateral surface of the cell; intracellular cGMP was actually lowered by butyrate treatment. Exposure of T84 cells to butyrate had no effect on the disposition of cyclic AMP generated in response to forskolin. The effects of butyrate on cGMP were reversible within 24 h of butyrate withdrawal. In colon cells, butyrate treatment induced a previously undescribed, cGMP-specific efflux mechanism which lowered intracellular cGMP and elevated extracellular cGMP in response to peptide agonists such as guanylin and STa.
authors.affiliation: Department of Medicine, State University of New York at Buffalo, Buffalo, New York, 14214, USA. jcrane@acsu.buffalo.edu
authors.forename: J K
authors.initials: JK
authors.lastname: Crane
mesh_terms: D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology; D020148:Butyric Acid / Q000494:pharmacology*; D019556:COS Cells; D018938:Caco-2 Cells; D002460:Cell Line; D003106:Colon / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004768:Enterotoxins / Q000494:pharmacology; D029968:Escherichia coli Proteins; D005768:Gastrointestinal Hormones; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism; D006801:Humans; D045265:Natriuretic Peptides; D010455:Peptides / Q000494:pharmacology; D014162:Transfection
chemical_list: D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D005768:Gastrointestinal Hormones; D045265:Natriuretic Peptides; D010455:Peptides; C034151:heat stable toxin (E coli); D020148:Butyric Acid; C072685:guanylin; C084362:uroguanylin; D006162:Guanylate Cyclase; D006152:Cyclic GMP